<DOC>
	<DOC>NCT01353274</DOC>
	<brief_summary>Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension</brief_summary>
	<brief_title>Safety and Efficacy of Daily Use of MicamloÂ® Combination Tablets AP in Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Inclusion criteria: Male and Female patients with hypertension who did not receive of MICAMLO Combination Tablets AP before the start of the study Exclusion criteria: Patients with a history of hypersensitivity to any ingredient of Micamlo Combination Tablets AP and dihydropyridine derivatives Pregnant woman or possibly pregnant woman Patients with extremely poor bile secretion or patients with serious hepatic disorder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>